There is no single “best” hospital for bile duct cancer, but a handful of centers in the United States consistently lead in treating this rare and complex disease. The hospitals that produce the best outcomes share key traits: high surgical volume, dedicated hepatobiliary teams, access to clinical trials, and specialized procedures you won’t find at a community hospital. Where you’re treated matters more for bile duct cancer than for many other cancers, because the surgery is technically demanding and the disease often requires a combination of approaches tailored by experienced specialists.
Why Hospital Choice Matters More for This Cancer
Bile duct cancer, also called cholangiocarcinoma, is one of the hardest cancers to treat surgically. Even after a complete tumor removal with curative intent, five-year survival sits at only 20 to 30 percent. Research published in the journal HPB found that hospitals performing 14 or more bile duct cancer operations per year had significantly lower short-term mortality and better long-term survival compared to lower-volume centers. Hospitals in the lowest volume category handled just zero to five cases per year, while high-volume centers saw 20 or more. Treatment at a high-volume hospital was independently linked to improved overall survival, as was receiving care that followed national treatment guidelines.
That volume threshold is important to keep in mind. Because bile duct cancer is rare, most hospitals simply don’t see enough cases to build deep expertise. Asking a prospective hospital how many cholangiocarcinoma cases their surgical team handles each year is one of the most practical things you can do when choosing where to go.
Top-Ranked Cancer Centers
The U.S. News & World Report rankings for cancer care provide a useful starting point, though they reflect overall oncology strength rather than bile duct cancer specifically. The top five for 2024–2025 are MD Anderson Cancer Center in Houston (score: 100/100), Memorial Sloan Kettering in New York (91.1), Dana-Farber Brigham Cancer Center in Boston (83.2), Mayo Clinic (82.4), and Massachusetts General Hospital (78.2). Rounding out the top ten are Mount Sinai Hospital, UCSF Medical Center, Johns Hopkins Hospital, Stanford Health Care, and City of Hope.
Several of these centers have built specific hepatobiliary programs focused on cancers of the liver, bile ducts, and gallbladder. That specialization is what you’re looking for, not just a high ranking in general oncology.
Centers With Dedicated Bile Duct Programs
MD Anderson Cancer Center
MD Anderson runs active clinical trials combining chemotherapy with surgery for biliary tumors and is exploring targeted therapies for specific genetic mutations commonly found in bile duct cancers. Their multidisciplinary team approach means your case is reviewed by surgeons, medical oncologists, and radiation specialists together rather than in isolation. For patients whose tumors carry certain molecular markers, targeted therapy trials at MD Anderson may offer options beyond standard chemotherapy.
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering offers a procedure few other hospitals perform: implantation of a hepatic artery infusion pump. This small device is surgically placed in the abdomen and connected to the main blood vessel feeding the liver, delivering chemotherapy directly to the tumor site at a steady rate. The surgery takes about one and a half to two hours. For patients with bile duct cancer that is confined to the liver but can’t be fully removed, this targeted delivery method concentrates treatment where it’s needed most while reducing the systemic side effects of standard chemotherapy.
Mayo Clinic
Mayo Clinic pioneered a structured protocol for treating a specific type of bile duct cancer called perihilar cholangiocarcinoma with liver transplantation. The protocol involves radiation and chemotherapy before transplant, and it has produced two-year overall survival rates of 65 to 70 percent, with five-year recurrence-free survival between 47 and 68 percent. Those numbers are striking compared to the 20 to 30 percent five-year survival seen with surgery alone. Eligibility is limited to patients with perihilar tumors that can’t be removed surgically or those who developed bile duct cancer in the context of a chronic liver condition called primary sclerosing cholangitis. Patients with PSC-associated bile duct cancer tend to do even better after transplant than those whose cancer arose on its own.
Mayo also runs one of the largest portfolios of bile duct cancer clinical trials in the country, with 67 active studies across its three campuses in Rochester, Minnesota (48 trials), Scottsdale/Phoenix, Arizona (41 trials), and Jacksonville, Florida (26 trials). The center also offers proton beam therapy, a form of radiation that delivers a more precise beam and can be particularly useful when tumors sit close to critical structures.
Johns Hopkins Hospital
Johns Hopkins operates a Liver and Biliary Cancer Multidisciplinary Clinic through its Sidney Kimmel Comprehensive Cancer Center. As one of the institutions that helped develop modern bile duct surgery techniques, it remains a high-volume referral center with deep surgical experience in hepatobiliary cases.
Winship Cancer Institute (Emory University)
Winship may not appear on the U.S. News top ten, but it runs a dedicated hepatobiliary cancer program where every team member, from the medical oncologist to the radiation oncologist to the surgeon, specializes specifically in liver and bile duct cancers. For patients in the Southeast, Winship offers NCI-designated comprehensive cancer center expertise without traveling to the Northeast or Texas.
What to Look for in Any Hospital
Beyond rankings and name recognition, a few concrete factors separate the best bile duct cancer care from average care:
- Surgical volume. At minimum, look for a center performing 14 or more bile duct cancer operations per year. High-volume centers (20 or more per year) consistently show better survival outcomes.
- Multidisciplinary tumor board. Your case should be reviewed by a team of specialists together, not just a single surgeon. This is standard at NCI-designated comprehensive cancer centers.
- Molecular profiling. Bile duct cancers frequently carry genetic mutations that can be targeted with newer therapies. A center that routinely tests for these markers gives you access to treatment options that might otherwise be missed.
- Clinical trial access. Because standard treatments for bile duct cancer remain limited, having access to trials testing new combinations of therapy can be genuinely meaningful, not just a nice extra.
- Liver transplant capability. If you have perihilar cholangiocarcinoma, being at a center that offers the transplant protocol could change your prognosis significantly. Only a limited number of transplant centers follow this approach.
Getting a Second Opinion Remotely
If traveling to a top center isn’t immediately feasible, several institutions offer remote second opinion programs where specialists review your pathology, imaging, and records and provide a treatment recommendation. The University of Colorado Cancer Center, for example, runs a remote second opinion program covering gastrointestinal cancers, though availability varies by specialty and time of year. MD Anderson, Mayo Clinic, and Memorial Sloan Kettering also have established pathways for remote consultations. A remote second opinion can confirm your current treatment plan or identify options, such as a clinical trial or transplant eligibility, that your local team may not have considered.